Table 1 Summary data for the entire cohort with evaluable data and those for analysis of changes in serum potassium and bicarbonate concentrations (Mean ± SD)
Patient characteristic or treatment parameter during daily HD | Evaluable cohort | Potassium cohort | Bicarbonate cohort |
|---|---|---|---|
Number of Patients (N) | 425 | 345 | 284 |
Age (years) | 52 ± 15 | 51 ± 15 | 51 ± 15 |
Pre-Enrollment Body Weight (kg) | 87.0 ± 23.8 | 86.5 ± 23.7 | 86.6 ± 23.2 |
Treatment Frequency per week | 5.9 ± 0.2 | 5.9 ± 0.2 | 5.9 ± 0.2 |
Dialysate Volume per treatment (L) | 22.3 ± 4.0 | 22.2 ± 4.0 | 22.1 ± 4.0 |
Weekly Dialysate Volume (L) | 131 ± 25 | 131 ± 24 | 131 ± 24 |
Blood Flow Rate (mL/min) | 465 ± 54 | 468 ± 52 | 469 ± 51 |
Dialysate Potassium Concentration (mEq/L) | 1.07 ± 0.27 | 1.06 ± 0.24 | 1.07 ± 0.27 |
Dialysate Lactate Concentrations (mEq/L) | 43.0 ± 3.1 | 43.0 ± 3.2 | 43.1 ± 2.4 |